# Invicta Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/invicta-medical

- Industry: Medical Devices & Equipment
- Headquarters: US
- Website: www.invictamedical.com
- Total disclosed funding: $26M
- Latest round: Series B (Dec 20, 2017)
- Investors on record: 6

## About

Invicta Medical, Inc. specializes in developing innovative neurostimulation technology aimed at treating sleep apnea, significantly improving patient comfort and compliance compared to traditional treatment methods.Invicta Medical, Inc. is a clinical-stage medical technology company founded in 2013 and headquartered in the United States. It focuses on advanced treatment options for sleep apnea. The company's CEO is Rick O'Connor. Invicta Medical has successfully raised a total of USD 3.73 mn through 4 funding rounds, with the latest being a Seed round in October 2021. This funding values the company at USD 12.23 mn post-money.Invicta Medical, Inc. develops a novel treatment for sleep apnea via its intelligent neurostimulation system, designed to overcome the limitations of conventional therapies like Continuous Positive Airway Pressure (CPAP) devices. Their non-invasive solution is tailored for healthcare providers, sleep clinics, and millions affected by sleep apnea globally, addressing crucial health risks associated with the condition, including hypertension and diabetes.Since its inception, Invicta Medical has raised USD 3.73 mn in funding, demonstrating investor confidence in its strategy and product development. Revenue is projected to come from partnerships with healthcare providers and medical facilities, as well as direct-to-consumer sales of its neurostimulation system, although specific pricing details are not available.Following a Seed funding round that concluded in October 2021, Invicta Medical, Inc. plans to utilize the raised USD 3.73 mn to further develop its neurostimulation technology and expand into new markets across North America, Europe, and Asia by 2023. The company is focused on enhancing its product offerings and increasing accessibility to its innovative solutions for sleep apnea.

## Funding rounds

- Series B, Dec 20, 2017, $21M — GreatPoint Ventures, Proton Enterprises, Eclipse Ventures, Rivendell Partners, R Ventures, Thiel Capital
- Series A, Jul 1, 2016, $5.5M — R Ventures, Thiel Capital
- Seed, Jan 1, 2015 — R Ventures

## Investors

- R Ventures (https://capitalatlas.ai/funds/r-ventures) — Seed, Series A, Series B
- Thiel Capital — Series A, Series B
- GreatPoint Ventures (https://capitalatlas.ai/funds/greatpoint-ventures) — Series B
- Proton Enterprises (https://capitalatlas.ai/funds/proton-enterprises) — Series B
- Eclipse Ventures (https://capitalatlas.ai/funds/eclipse-ventures) — Series B
- Rivendell Partners (https://capitalatlas.ai/funds/rivendell-partners) — Series B